CN1850110A - Medicine for treating oral mucositis - Google Patents
Medicine for treating oral mucositis Download PDFInfo
- Publication number
- CN1850110A CN1850110A CN 200510065885 CN200510065885A CN1850110A CN 1850110 A CN1850110 A CN 1850110A CN 200510065885 CN200510065885 CN 200510065885 CN 200510065885 A CN200510065885 A CN 200510065885A CN 1850110 A CN1850110 A CN 1850110A
- Authority
- CN
- China
- Prior art keywords
- medicine
- stomatitis
- sodium carbonate
- treatment
- sodium benzoate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The present invention relates to a medicine for curing stomatitis. Its composition includes (by weight portion) 20-35 portions of sodium carbonate, 20-35 portions of lime powder and 30-45 portions of sodium benzoate.
Description
Technical field
The present invention relates to a kind of medicine for the treatment of stomatitis.
Background technology
Stomatitis is a kind of common multiple oral cavity infection disease, can be divided into thrush, herpetic stomatitis, angular cheilitis and gingivitis again according to the position and the reason of falling ill, and is mainly caused by antibacterial.Thrush is to be caused by Candida albicans; Herpetic stomatitis causes by herpetic virus, commonly herpes simplex 1 type virus; The reason that causes angular cheilitis has infective agent, also nutritious factor (as Vitamin B2 deficiency).Oral ulcer often occurs in tongue, cheek, palate, lip is inboard and pharyngeal etc. located.The expansion lip outside and the bicker that have.The ulcer that differs in size appears in time-out oral mucosa hyperemia just and edema soon, and what have is linked to be sheet, and ulcer surface is canescence.At present the main way of treatment stomatitis is to smear or with ribavirin intramuscular injection or oral Radix Isatidis granules and vitamin B at the different causes of disease or with Gentian Violet.But mostly curative effect is slow, bactericidal effect is poor for these medicines.
Summary of the invention
The purpose of this invention is to provide that a kind of curative effect is fast, effective, the medicine of the treatment stomatitis that is not easy to recur after curing.
For achieving the above object, the present invention adopts following technical scheme:
A kind of medicine for the treatment of stomatitis of the present invention is mixed by following components by weight portion
Sodium carbonate 20---35 pulverized limestones 20---35 sodium benzoate 30---45.
Said medicine is mixed by following components by weight portion
Sodium carbonate 30 pulverized limestones 30 sodium benzoate 40.
Sodium carbonate is commonly called as soda, has another name called soda.Be white powder, soluble in water, be alkalescence.The sodium carbonate of food stage is commonly used does food additive, and proper amount of edible is harmless.The main component of pulverized limestone is a calcium carbonate, itself is not alkalescence, but with water reaction after be alkalescence.Sodium benzoate white crystals shape powder or snowflake are also or granule, and be stable in the air, very easily water-soluble.The antiseptic of cooking food or medicine commonly used.Above-mentioned three kinds of components spread upon ill position, oral cavity after mixing, and have the effect of good sterilization antiinflammatory, the malignant bacteria of multiple stomatitis is all had good killing action, and be not easy recurrence after curing.
Investigation by the 20 routine stomatitis patients that randomly draw shows, adopts the stomatitis patient of traditional method treatment, healing time generally a week above account for 50%, cure recur again in back 2 months account for 10%.And adopting 20 routine patients' the follow up survey of the Drug therapy of treatment stomatitis of the present invention to show: 90% patient fully recover in 3 days, and did not have an example to recur.
The specific embodiment
Embodiment 1,
A kind of medicine for the treatment of stomatitis of the present invention mixes sodium carbonate 20 by following components by weight portion: pulverized limestone 20: sodium benzoate 30.Above-mentioned three kinds of components all select for use the dusty raw materials of food stage to mix, as long as medicamental pulverata is spread upon disease sites, smear once in 3,4 hours during use, smear 3-4 time and get final product generally continuously.
Embodiment 2,
Above-mentioned each component ratio is adjusted into sodium carbonate 35: pulverized limestone 35: sodium benzoate 45.
Embodiment 3,
Above-mentioned each component ratio is adjusted into sodium carbonate 35: pulverized limestone 30: sodium benzoate 45.
Embodiment 4,
Above-mentioned each component ratio is adjusted into sodium carbonate 30: pulverized limestone 30: sodium benzoate 40.
Claims (2)
1, a kind of medicine for the treatment of stomatitis is characterized in that this medicine is mixed by following components by weight portion
Sodium carbonate 20--35 pulverized limestone 20--35 sodium benzoate 30--45.
2, a kind of medicine for the treatment of stomatitis according to claim 1 is characterized in that this medicine is mixed by following components by weight portion
Sodium carbonate 30 pulverized limestones 30 sodium benzoate 40.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 200510065885 CN1850110A (en) | 2005-04-22 | 2005-04-22 | Medicine for treating oral mucositis |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 200510065885 CN1850110A (en) | 2005-04-22 | 2005-04-22 | Medicine for treating oral mucositis |
Publications (1)
Publication Number | Publication Date |
---|---|
CN1850110A true CN1850110A (en) | 2006-10-25 |
Family
ID=37131622
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 200510065885 Pending CN1850110A (en) | 2005-04-22 | 2005-04-22 | Medicine for treating oral mucositis |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1850110A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113678829A (en) * | 2021-08-27 | 2021-11-23 | 厦门保沣实业有限公司 | Antibacterial agent and its production process |
-
2005
- 2005-04-22 CN CN 200510065885 patent/CN1850110A/en active Pending
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113678829A (en) * | 2021-08-27 | 2021-11-23 | 厦门保沣实业有限公司 | Antibacterial agent and its production process |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1627951A (en) | Compositions and method for prophylaxis and treatment of aphthous ulcers and herpes simplex lesions | |
CN1748571A (en) | Calcium supplementing health food base materials | |
CN101904866A (en) | Medicinal composition for treating osteoporosis and preparation method thereof | |
CN1919170A (en) | Colloid pectin bismuth dry suspensoid and its preparing process | |
CN1850110A (en) | Medicine for treating oral mucositis | |
CN1195544C (en) | Liver function ameliorating agents | |
CN1742741A (en) | Medicinal composition containing amino glucose and calcium agent and vitamin D and use thereof | |
CN1809367A (en) | A method of treating or preventing chronic wounds and a complete nutritional composition comprising glycine and/or leucine for use therein | |
CN110269099B (en) | Composition of multiple pH buffer formula and protein digestive aid and application thereof | |
CN1129452C (en) | Buccal tablet of epidermal growth factor | |
CA2829832C (en) | Use of a sprayable composition comprising ambroxol | |
CN101125147B (en) | Glucosamine calcium medicine preparation, preparation method and application thereof | |
CN1078468C (en) | Health-care products composition | |
CN1168634A (en) | Kit for osteoporosis treatment cycle | |
CN1132593C (en) | Mixture of white pepper and borneol and its application | |
CN111012900B (en) | Composition with bone mineral density increasing function and preparation method and application thereof | |
CN1240426C (en) | Prepared Chinese medicine for treating ulcerative stomatitis | |
JPS61254162A (en) | Calcium-containing health food | |
CN1899302A (en) | Oral sticking plaster preparation for treating oral ulcer and its preparing method | |
WO2002028400A1 (en) | A therapeutic formulation containing glucosamine, methylsulfonymethane and eventually ascorbic acid and manganese | |
CN1247204C (en) | Medicine for treating beri-beri | |
RU2148942C1 (en) | Biologically-active food additive | |
CN1307820A (en) | Efficient safe premixed pig feed | |
CN1433778A (en) | Powder medicine for treating otitis media and preparation method thereof | |
CN1440291A (en) | Pharmaceutical composition based on non-steroid anti-inflammatory agent |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |